[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100650839":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":10,"locations":15,"responsibleParty":46,"collaborators":10,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":10,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":10,"enrollmentInfo":60,"targetDuration":63,"studyType":64,"phases":10,"briefSummary":65,"conditions":66,"keywords":70,"overallStatus":77,"whyStopped":10,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Hacettepe University","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Hypogonadism Group (Case)",null,"Male patients aged 18 years or older with biochemically confirmed hypogonadism (total testosterone \\\u003C 300 ng\u002FdL with at least one clinical symptom) undergoing regular follow-up in the endocrinology clinic.",{"label":13,"type":10,"description":14,"interventionNames":10},"Control Group (Other Chronic Endocrine Diseases)","Male patients aged 18 years or older diagnosed with diabetes mellitus, hypertension, or hypothyroidism without hypogonadism (total testosterone ≥ 300 ng\u002FdL), matched by age (±5 years) to the case group and under regular follow-up in the same endocrinology clinic.",[16,33],{"facility":17,"status":10,"city":18,"state":10,"zip":10,"country":19,"countryCode":10,"cosmosGeoPoint":20,"geoPoint":25,"contacts":26},"Bingöl University Faculty of Physical Therapy and Rehabilitation","Bingoel","Turkey (Türkiye)",{"type":21,"coordinates":22},"Point",[23,24],40.49389,38.88472,{"lat":24,"lon":23},[27],{"name":28,"role":29,"phone":30,"phoneExt":31,"email":32},"Aybüke Fanuscu, Pt, PhD","CONTACT","+904262160012","5548","afanuscu@bingol.edu.tr",{"facility":34,"status":10,"city":35,"state":10,"zip":10,"country":19,"countryCode":10,"cosmosGeoPoint":36,"geoPoint":40,"contacts":41},"Malatya Training and Research Hospital","Malatya",{"type":21,"coordinates":37},[38,39],38.31667,38.35018,{"lat":39,"lon":38},[42],{"name":43,"role":29,"phone":44,"phoneExt":10,"email":45},"Emine Şener Aydın, MD","+904222118019","dreminesener@windowslive.com",{"type":47,"investigatorFullName":48,"investigatorTitle":49,"investigatorAffiliation":50,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Aybüke Fanuscu","Assistant Professor","Bingol University","100650839","anticipated-stigma-illness-identity-and-quality-of-life-in-male-hypogonadism-100650839",false,"NCT07752511","Anticipated Stigma, Illness Identity, and Quality of Life in Male Hypogonadism","The Impact of Anticipated Illness Stigma and Illness Identity on Quality of Life in Men With Hypogonadism: A Comparative Study With Other Chronic Endocrine Diseases","Inclusion Criteria:\n\nCases:\n\n* Male, aged 18 years or older.\n* Biochemically confirmed hypogonadism (total testosterone \\\u003C 300 ng\u002FdL with at least one clinical symptom).\n* Regular follow-up at the endocrinology outpatient clinic.\n* Fluent in reading and understanding Turkish.\n* Signed informed consent.\n\nControls:\n\n* Male, aged 18 years or older.\n* Diagnosed with diabetes, hypertension, or hypothyroidism under regular endocrinology follow-up.\n* Total testosterone ≥ 300 ng\u002FdL.\n* Age-matched to a participant in the case group (±5 years).\n* Fluent in reading and understanding Turkish.\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Active psychiatric diagnosis (e.g., active psychosis, bipolar disorder).\n* Chronic inflammatory or rheumatological diseases affecting body composition (e.g., chronic kidney disease, IBD, rheumatoid arthritis, SLE, ankylosing spondylitis).\n* Uncontrolled co-existing endocrine conditions or severe complications (e.g., HbA1c \\> 8.0%, diabetic neuropathy\u002Fnephropathy\u002Fretinopathy, non-euthyroid state).\n* Cognitive impairment or dementia precluding questionnaire completion.\n* Klinefelter syndrome.\n* Literacy limitations preventing completion of self-report measures.\n* Additional control exclusion: Diagnosis or clinical suspicion of hypogonadism.","MALE","18 Years",{"count":61,"type":62},90,"ESTIMATED","1 Day","OBSERVATIONAL","This study aims to systematically compare the levels of anticipated illness stigma and illness identity among men diagnosed with hypogonadism to those of men with other chronic endocrine conditions (e.g., diabetes mellitus, hypothyroidism, and hypertension). Furthermore, it examines whether these psychosocial variables predict quality-of-life deterioration specifically within the hypogonadism cohort.",[67,68,69],"Hypogonadism, Male","Endocrine Disease","Hypertension",[71,72,73,74,75,76],"Hypogonadism","Anticipated Stigma","Illness Identity","Quality of Life","Chronic Endocrine Diseases","Psychosocial Factors","NOT_YET_RECRUITING","2026-08-04",{"date":80,"type":81},"2026-08-07","ACTUAL",{"date":83,"type":62},"2026-10-01",{"date":85,"type":62},"2027-10-30",{"name":5,"class":6},2]